富祥股份(300497.SZ):擬投50億元建富祥生物醫藥項目
格隆匯3月29日丨富祥股份(300497.SZ)公佈,2020年3月29日,公司召開第三屆董事會第十會議,審議通過了《關於與景德鎮市人民政府簽訂戰略合作協議書的議案》,同意公司以自有資金或自籌資金在景德鎮國家高新技術產業開發區國電投景德鎮發電廠西南側投資建設富祥生物醫藥項目。
為了提升公司在原料藥、醫藥中間體的市場競爭力,進一步拓寬企業發展空間,公司擬設立全資子公司景德鎮富祥生命科技有限公司(暫定名,以企業登記機關最終核准結果為準),在景德鎮國家高新技術產業開發區國電投景德鎮發電廠西南側投資建設富祥生物醫藥項目,項目用地約1001畝,總投資50億元人民幣,建設年產2500噸手性藥物、1200噸生物製藥、5億片(包/支)藥物製劑的生產基地。項目名稱和建設內容最終以相關政府主管機關的批准文件為準。
其中一期新建年產1600噸手性藥物原料藥及其高級中間體生產線和多功能CDMO製造中心、綜合利用、倉儲、質檢、公用工程、三廢治理、生活辦公等配套設施。
此次簽訂合同主要是投資建設富祥生物醫藥項目,充分發揮公司現有產業技術優勢和產業集聚效應,推進產業鏈的延伸和優化,拓寬企業發展空間,實現新舊動能轉換和企業的高質量發展。另外可充分發揮項目選址臨近國道、高速、高鐵站、機場以及內河港口的交通優勢,充分利用景德鎮發電廠的直供電、蒸汽、水等能源集約優勢,全面降低綜合生產成本,提高公司產品的整體市場競爭力。
協議的簽署,符合公司的戰略發展需要,有助於公司完善業務佈局,形成新的利潤增長點,為公司的長遠發展奠定堅實的基礎。公司將繼續加快項目建設,積極響應和滿足市場需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.